PGDH Antibodies

Santa Cruz Biotechnology delivers a wide array of PGDH monoclonal antibodies for investigating phosphoglycerate dehydrogenase (PGDH) in various biological processes. PGDH monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phosphoglycerate dehydrogenase (PGDH) is a key enzyme in the serine biosynthesis pathway, catalyzing the conversion of 3-phosphoglycerate to 3-phosphohydroxypyruvate. PGDH plays a crucial role in cellular metabolism and is involved in the regulation of amino acid synthesis, which is vital for cell growth and proliferation. Research has shown that PGDH expression levels can vary significantly in different tissue types and developmental stages. Understanding PGDH activity and regulation provides valuable insights into metabolic pathways and cellular homeostasis. Dysregulation of PGDH has been implicated in various diseases, particularly in cancer and metabolic disorders. Ongoing studies continue to reveal new aspects of PGDH function in cellular processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PGDH and its role in human health and disease.